Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Muntañola · SciRah

Researcher profile · Semantic Scholar

A. Muntañola

Share profile

A. Muntañola — researcher profile on SciRah

h-index: 22
Works: 68
Citations: 3,047

Most-cited papers

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
S. Beá, R. Valdés-Mas, A. Navarro, I. Salaverria +41 more
2013Proceedings of the National Academy of Sciences of the United States of America638 citations Open access
Semantic Scholar
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior
E. Giné, Antonio Martínez, N. Villamor, A. López-Guillermo +11 more
2010Haematologica309 citations Open access
Semantic Scholar
Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
A. López-Guillermo, L. Colomo, M. Jimenez, F. Bosch +9 more
2005Journal of Clinical Oncology286 citations Open access
Semantic Scholar
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia.
A. Álvarez-Larrán, F. Cervantes, A. Pereira, E. Arellano-Rodrigo +11 more
2010Blood232 citations Open access
Semantic Scholar
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes.
F. Nadeu, D. Martín-Garcia, G. Clot, A. Díaz-Navarro +27 more
2020Blood182 citations Open access
Semantic Scholar
Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience.
P. Abrisqueta, A. Pereira, C. Rozman, M. Aymerich +9 more
2009Blood158 citations Open access
Semantic Scholar
Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
F. Bosch, P. Abrisqueta, N. Villamor, M. Terol +16 more
2009Journal of Clinical Oncology144 citations Open access
Semantic Scholar
Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia.
Carol Moreno, N. Villamor, D. Colomer, J. Esteve +5 more
2005Blood134 citations
Semantic Scholar
Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication
F. Bosch, A. Ferrer, N. Villamor, Marcos González +16 more
2008Clinical Cancer Research120 citations
Semantic Scholar
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.
A. Salar, E. Domingo-Domènech, C. Panizo, C. Nicolás +17 more
2014The Lancet Haematology90 citations Open access
Semantic Scholar
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
A. Salar, E. Domingo-Domènech, C. Panizo, C. Nicolás +17 more
2017Blood82 citations
Semantic Scholar
ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia
M. Crespo, N. Villamor, E. Giné, A. Muntañola +7 more
2006Clinical Cancer Research69 citations Open access
Semantic Scholar
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.
G. Clot, P. Jares, E. Giné, A. Navarro +23 more
2018Blood65 citations Open access
Semantic Scholar
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.
P. Abrisqueta, N. Villamor, M. Terol, E. González-Barca +18 more
2013Blood61 citations Open access
Semantic Scholar
Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia.
A. Muntañola, F. Bosch, P. Arguis, E. Arellano-Rodrigo +8 more
2007Journal of Clinical Oncology58 citations Open access
Semantic Scholar
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
E. Giné, F. de la Cruz, Ana Jiménez Ubieto, J. López-Jiménez +19 more
2022Journal of Clinical Oncology53 citations Open access
Semantic Scholar
Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients
F. Plancarte, A. López-Guillermo, L. Arenillas, S. Montoto +9 more
2006European Journal of Haematology37 citations
Semantic Scholar
Successful treatment by selective arterial embolization of severe retroperitoneal hemorrhage secondary to bone marrow biopsy in post-polycythemic myelofibrosis
E. Arellano-Rodrigo, M. Real, A. Muntañola, M. Burrel +3 more
2003Annals of Hematology37 citations
Semantic Scholar
A new molecular assay and genomic complexity predict outcome in conventional and leukemic non-nodal mantle cell lymphoma
G. Clot, P. Jares, E. Giné, A. Navarro +23 more
201834 citations
Semantic Scholar
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group
M. Bastos-Oreiro, A. Muntañola, C. Panizo, E. González-Barca +36 more
2020Annals of Hematology32 citations
Semantic Scholar
Clinical implications of ZAP‐70 expressionin chronic lymphocytic leukemia
F. Bosch, A. Muntañola, E. Giné, A. Carrió +4 more
2006Cytometry. Part B, Clinical cytometry32 citations Open access
Semantic Scholar
Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment
E. Giné, M. Crespo, A. Muntañola, E. Calpe +4 more
2008Haematologica28 citations Open access
Semantic Scholar
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
A. Muntañola, G. Villacampa, J. Hernandez-rivas, R. Alonso +42 more
2020Experimental Hematology & Oncology15 citations Open access
Semantic Scholar
Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
M. Baptista, G. Tapia, A. Muñoz-Marmol, J. Muncunill +27 more
2022Histopathology13 citations Open access
Semantic Scholar
Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable outcome
A. Muntañola, P. Mozas, S. Mercadal, M. Huguet +16 more
2022British Journal of Haematology13 citations
Semantic Scholar
Idiopathic Myelofibrosis Associated with Classic Polyarteritis Nodosa
M. Camós, E. Arellano-Rodrigo, D. Abelló, A. Muntañola +3 more
2003Leukemia and Lymphoma12 citations
Semantic Scholar
Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
A. Rivas-Delgado, C. López, G. Clot, F. Nadeu +29 more
2024HemaSphere11 citations Open access
Semantic Scholar
Final Results of a Multicenter Phase II Trial with Bendamustine and Rituximab As First Line Treatment for Patients with MALT Lymphoma (MALT-2008–01)
A. Salar, E. Domingo-Domènech, C. Panizo, C. Nicolás +15 more
201211 citations
Semantic Scholar
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial
L. Magnano, S. Montoto, E. González-Barca, J. Briones +19 more
2017Annals of Hematology8 citations
Semantic Scholar
Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM) Is a Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia.
F. Bosch, P. Abrisqueta, N. Villamor, M. Terol +14 more
20088 citations
Semantic Scholar
Clinical Characteristics and Outcome of a Large Series of Patients with Chronic Lymphocytic Leukemia (CLL) According to ZAP-70 Expression.
F. Bosch, M. Crespo, N. Villamor, A. Muntañola +6 more
20048 citations
Semantic Scholar
In silico analysis of atrial fibrillation and hypertension mechanism of action secondary to ibrutinib/acalabrutinib in chronic lymphocytic leukemia
R. Córdoba, A. Bayés-Genís, A. Muntañola, D. Colomer +4 more
2025Scientific Reports7 citations Open access
Semantic Scholar
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
I. López-Oreja, M. López-Guerra, J. Correa, P. Mozas +10 more
2023HemaSphere7 citations Open access
Semantic Scholar
Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) After Upfront Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM): Final Results of a Multicenter Phase II Trial On Behalf of the Spanish CLL Study Group (GELLC)
F. Bosch, P. Abrisqueta, N. Villamor, M. Terol +15 more
20116 citations
Semantic Scholar
bendamustine Plus Rituximab In First Line Systemic Treatment For Extranodal Malt Lymphoma: Final Results Of Phase Ii Trial Of The Spanish Lymphoma Study Group (geltamo) : 100
A. Salar, E. Domingo-Domènech, C. Panizo, C. Nicolás +15 more
20135 citations
Semantic Scholar
Differential Gene Expression Profile Associated to Apoptosis Induced by Dexamethasone in CLL Cells According to IGHV/ZAP-70 Status
M. Baptista, A. Muntañola, E. Calpe, P. Abrisqueta +7 more
2012Clinical Cancer Research5 citations Open access
Semantic Scholar
Preliminary Results of the Combination Rituximab, Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) Followed by Rituximab Maintenance in Previously Untreated Chronic Lymphocytic Leukemia (CLL).
F. Bosch, A. Muntañola, N. Villamor, M. Terol +15 more
20075 citations
Semantic Scholar
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC).
Á. Medina, A. Muntañola, M. Crespo, Ángel Ramírez +12 more
2025Medicina clínica (Ed. impresa)4 citations
Semantic Scholar
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
A. Muntañola, T. Baumann, A. Caballero, B. Sánchez-González +12 more
2020Annals of Hematology4 citations
Semantic Scholar
Biological Analysis and Prognostic Significance of Proliferative Cellular Compartment in Chronic Lymphocytic Leukemia (CLL).
P. Abrisqueta, N. Villamor, A. Muntañola, C. Codony +12 more
20094 citations
Semantic Scholar
Ocular involvement in patients with primary central‐nervous‐system lymphoma: Analysis of a multicentre study in Spain
S. Mercadal, M. Alañá, M. Barceló, G. Bruixola +16 more
2022British Journal of Haematology3 citations
Semantic Scholar
PACE as salvage therapy for relapsed or refractory multiple myeloma
I. Isola, M. Granell, J. Martí, M. Gironella +10 more
20153 citations
Semantic Scholar
Computed Tomography (CT) Predicts Response Duration in Patients with Chronic Lymphocytic Leukemia (CLL) in Complete Response (CR) by Conventional, NCI-Working Group, Criteria.
F. Bosch, A. Muntañola, A. Ferrer, Marcos González +11 more
20063 citations
Semantic Scholar
New therapies for relapsed or refractory aggressive B‐cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group
M. Bastos-Oreiro, P. Abrisqueta, Antonio-M. Gutierrez, Ana Jiménez Ubieto +18 more
2024HemaSphere2 citations Open access
Semantic Scholar
Low‐risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study
A. Muntañola, María Teresa Villalobos, S. González-Villambrosia, M. Rodríguez-Salazar +20 more
2023British Journal of Haematology2 citations Open access
Semantic Scholar
Retreatment with full-dose cytarabine in a patient with previous neurological toxicity
Núria Meca Casasnovas, A. Manzaneque, A. Muntañola, Genís Castells
2022Journal of Oncology Pharmacy Practice2 citations
Semantic Scholar
Bilateral phrenic nerve palsy induced by subcutaneous bortezomib in a patient with newly diagnosed multiple myeloma: first case reported
M. López, Xavier Martínez Lacasa, J. Martí, A. Muntañola +9 more
2017Leukemia and Lymphoma2 citations
Semantic Scholar
Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) Sustains the Response Obtained After First-Line Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM).
F. Bosch, N. Villamor, P. Abrisqueta, M. Terol +15 more
20102 citations
Semantic Scholar
Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting
A. Muntañola, J. M. Arguiñano-Pérez, J. Dávila, Sonia González Villambrosia +3 more
2022Clinical and Translational Science1 citations Open access
Semantic Scholar
FMNL-1 (Formin-Like 1) Gene in Chronic Lymphocytic Leukemia (CLL) Is Overexpressed in Young Patients with Adverse Prognostic Factors and Poor Outcome.
E. Calpe, P. Favaro, M. Crespo, M. Baptista +5 more
20061 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Bosch×22
Invite
F. Bosch — researcher profile on SciRah
E. Montserrat×20
Invite
E. Montserrat — researcher profile on SciRah
N. Villamor×19
Invite
N. Villamor — researcher profile on SciRah
E. Giné×18
Invite
E. Giné — researcher profile on SciRah

A. López-Guillermo

×16

Invite

A. López-Guillermo — researcher profile on SciRah

P. Abrisqueta×16

Invite

P. Abrisqueta — researcher profile on SciRah

Invite

A. Salar — researcher profile on SciRah

Invite

L. Escoda — researcher profile on SciRah

Invite

E. Campo — researcher profile on SciRah

Invite

M. Terol — researcher profile on SciRah

E. González-Barca×10

Invite

E. González-Barca — researcher profile on SciRah

Invite

E. Abella — researcher profile on SciRah